miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- An emphasis on the interaction of signaling pathways.

[1]  A. El-Husseiny,et al.  miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review. , 2023, Pathology, research and practice.

[2]  Sylvia F. Fawzi,et al.  The role of miRNAs in insulin resistance and diabetic macrovascular complications - A review. , 2023, International journal of biological macromolecules.

[3]  M. Elkady,et al.  miRNAs as cornerstones in adipogenesis and obesity. , 2023, Life sciences.

[4]  Xiaohui Lin,et al.  Defining disease-related modules based on weighted miRNA synergistic network , 2023, Comput. Biol. Medicine.

[5]  H. M. El-Husseiny,et al.  miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers. , 2022, Life sciences.

[6]  M. Eldeib,et al.  miRNAs as cornerstones in diabetic microvascular complications. , 2022, Molecular genetics and metabolism.

[7]  M. Abdel-Daim,et al.  Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions , 2022, Biomedicine & Pharmacotherapy.

[8]  Zai‐Sheng Wu,et al.  Target-Induced Multiple Palindrome-Mediated Strand Displacement Amplification of Scarecrow-Shaped DNA Nanoprobe for Ultrasensitive Detection of MicroRNA , 2022, Sensors and Actuators B: Chemical.

[9]  Ahmed S. Doghish,et al.  The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay. , 2022, Pathology, research and practice.

[10]  M. Sobhy,et al.  Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase. , 2022, Pathology, research and practice.

[11]  D. O’Carroll,et al.  Structural and functional basis of mammalian microRNA biogenesis by Dicer , 2022, Molecular cell.

[12]  Ahmed S. Doghish,et al.  Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review. , 2022, International journal of biological macromolecules.

[13]  N. Hamdy,et al.  Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association. , 2022, Pathology, research and practice.

[14]  T. Al-Warhi,et al.  Identification of Novel Cyanopyridones and Pyrido[2,3-d]pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies , 2022, Pharmaceuticals.

[15]  S. Salem,et al.  Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: Synthesis, characterization, antimicrobial, and anticancer activities , 2022, Journal of Drug Delivery Science and Technology.

[16]  M. Hashemi,et al.  Crosstalk of miRNAs With Signaling Networks in Bladder Cancer Progression: Therapeutic, Diagnostic and Prognostic Functions. , 2022, Pharmacological research.

[17]  M. Saravanan,et al.  Role of dysregulated miRNAs profiles as hallmarks in the pathogenesis and differential regulation of tongue squamous cell carcinoma. , 2022, Oral Oncology.

[18]  N. Hamdy,et al.  Interactome battling of lncRNA CCDC144NL-AS1: Its role in the emergence and ferocity of cancer and beyond. , 2022, International journal of biological macromolecules.

[19]  Xue Han,et al.  The emerging role of noncoding RNAs in the Hedgehog signaling pathway in cancer. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  M. Asadi-Samani,et al.  Decreased cell proliferation and induced apoptosis in human B-chronic lymphocytic leukemia following miR-221 inhibition through modulation of p27 expression , 2022, Egyptian Journal of Medical Human Genetics.

[21]  Ahmed S. Doghish,et al.  Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: A review. , 2022, Life sciences.

[22]  M. Bayat,et al.  MiRNA-16-1 Suppresses Mcl-1 and Bcl-2 and Sensitizes Chronic Lymphocytic Leukemia Cells to BH3 Mimetic ABT-199 , 2022, Cell journal.

[23]  S. Salem,et al.  Synthesis of Silver Nanocomposite Based on Carboxymethyl Cellulose: Antibacterial, Antifungal and Anticancer Activities , 2022, Polymers.

[24]  N. El‐Ashmawy,et al.  Carnosine and crocin ameliorate oxidative stress in rats with rhabdomyolysis-induced acute kidney injury through upregulating HO-1 gene expression , 2022, Food Bioscience.

[25]  Behnaz Nateghi,et al.  miR-574, miR-499, miR-125b, miR-106a, and miR-9 potentially target TGFBR-1 and TGFBR-2 genes involving in inflammatory response pathway: Potential novel biomarkers for chronic lymphocytic leukemia. , 2022, Pathology, research and practice.

[26]  F. Ari,et al.  Mitochondrial miRNAs (MitomiRs): Their Potential Roles in Breast and Other Cancers. , 2022, Mitochondrion.

[27]  Ahmed S. Doghish,et al.  A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay. , 2022, Pathology, research and practice.

[28]  M. Cilli,et al.  MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells , 2022, Blood advances.

[29]  W. Elkhatib,et al.  Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt , 2022, PloS one.

[30]  A. A. Ahmed,et al.  miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review. , 2022, International journal of biological macromolecules.

[31]  A. Rosenwald,et al.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms , 2022, Leukemia.

[32]  L. Staudt,et al.  The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee. , 2022, Blood.

[33]  W. El‐Sayed,et al.  Discovery of pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as novel CDK2 inhibitors: synthesis, biological and molecular modeling investigations , 2022, RSC advances.

[34]  N. Mesbah,et al.  Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis. , 2022, Life sciences.

[35]  Al-aliaa M. Sallam,et al.  miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. , 2022, Pathology, research and practice.

[36]  M. Abulsoud,et al.  Genetic impact of vitamin D receptor TaqI polymorphism on the risk of osteoporotic fractures in diabetic patients , 2022, Gene Reports.

[37]  A. Filip,et al.  Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations , 2022, Molecular medicine reports.

[38]  M. M. Khalifa,et al.  New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies , 2021, Journal of enzyme inhibition and medicinal chemistry.

[39]  I. Eissa,et al.  1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies , 2021, Journal of enzyme inhibition and medicinal chemistry.

[40]  F. Marofi,et al.  MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers , 2021, Genes & diseases.

[41]  A. Ismail,et al.  A review of the biological role of miRNAs in prostate cancer suppression and progression. , 2021, International journal of biological macromolecules.

[42]  A. Almasan,et al.  Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies , 2021, Cell Death & Disease.

[43]  D. Frank,et al.  STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications , 2021, Neoplasia.

[44]  M. Hallek,et al.  Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures , 2021, American journal of hematology.

[45]  Alex J. Smith,et al.  Non-Coding RNA and Frizzled Receptors in Cancer , 2021, Frontiers in Molecular Biosciences.

[46]  G. Calin,et al.  Classical and noncanonical functions of miRNAs in cancers. , 2021, Trends in genetics : TIG.

[47]  Yu Feng,et al.  Structural basis of microRNA processing by Dicer-like 1 , 2021, Nature Plants.

[48]  Kumar Ponnuchamy,et al.  Transcriptional expression of miRNAs under glucose depletion/2-deoxy-d-glucose in HCC: A possible genetic footprints of angiogenesis and its hallmarks , 2021 .

[49]  W. E. El Rouby,et al.  Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer , 2021, RSC advances.

[50]  M. Saad,et al.  Agomelatine attenuates alcohol craving and withdrawal symptoms by modulating the Notch1 signaling pathway in rats. , 2021, Life sciences.

[51]  N. Hajjar,et al.  The Role of miR-155 in Nutrition: Modulating Cancer-Associated Inflammation , 2021, Nutrients.

[52]  N. Hamdy,et al.  MicroRNAs’ role in the environment-related non-communicable diseases and link to multidrug resistance, regulation, or alteration , 2021, Environmental Science and Pollution Research.

[53]  W. Elkhatib,et al.  Clinical characteristics of Egyptian male patients with COVID‐19 acute respiratory distress syndrome , 2021, PloS one.

[54]  M. Elshafey,et al.  MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8 , 2021, Saudi journal of biological sciences.

[55]  H. Pai,et al.  Light-Stabilized FHA2 Suppresses miRNA Biogenesis through Interactions with DCL1 and HYL1. , 2021, Molecular plant.

[56]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[57]  A. Amin,et al.  Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients With Metabolic Syndrome. , 2021, Canadian journal of diabetes.

[58]  E. M. Gedawy,et al.  Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers , 2021, Journal of enzyme inhibition and medicinal chemistry.

[59]  A. García-Pardo,et al.  Regulation and function of angiogenic factors in chronic lymphocytic leukemia , 2021, Journal of Cancer Metastasis and Treatment.

[60]  U. Jaeger,et al.  miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors. , 2020, Blood.

[61]  R. Gale,et al.  Ethnic and geographic diversity of chronic lymphocytic leukaemia , 2020, Leukemia.

[62]  Y. Kandil,et al.  Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein. , 2020, Life sciences.

[63]  G. Calin,et al.  Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia , 2020, International journal of molecular sciences.

[64]  Jianying Chen,et al.  MicroRNA-425 inhibits proliferation of chronic lymphocytic leukaemia cells through regulation of the Bruton's tyrosine kinase/phospholipase Cγ2 signalling pathway. , 2020, Experimental and Therapeutic Medicine.

[65]  B. Elsadek,et al.  Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase , 2020, Steroids.

[66]  Yan Wang,et al.  Upregulation of microRNA-1 inhibits proliferation and metastasis of breast cancer , 2020, Molecular medicine reports.

[67]  B. Elsadek,et al.  Androgen/androgen receptor affects gentamicin-induced nephrotoxicity through regulation of megalin expression. , 2020, Life sciences.

[68]  Kou-Juey Wu.  The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness , 2020, Biomedical journal.

[69]  T. Kalantari,et al.  Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients , 2020, Journal of blood medicine.

[70]  J. Ajani,et al.  Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility , 2020, Gut.

[71]  Jing Wang,et al.  Loss of p53 drives neuron reprogramming in head and neck cancer , 2020, Nature.

[72]  Zeyu Luo,et al.  Downregulation of microRNA let‐7f mediated the Adriamycin resistance in leukemia cell line , 2019, Journal of cellular biochemistry.

[73]  M. Hallek.  Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment , 2019, American journal of hematology.

[74]  Hong Liu,et al.  miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations. , 2019, Molecular and cellular probes.

[75]  Ting Huyan,et al.  MicroRNAs: Key Players in Bladder Cancer , 2019, Molecular Diagnosis & Therapy.

[76]  P. Chain,et al.  MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential , 2019, Genes.

[77]  S. Rahgozar,et al.  The Hedgehog signal transducer Smoothened and microRNA-326: pathogenesis and regulation of drug resistance in pediatric B-cell acute lymphoblastic leukemia , 2019, Cancer management and research.

[78]  S. Haan,et al.  Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells , 2019, Cells.

[79]  S. Chocholska,et al.  Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients , 2019, Cancer management and research.

[80]  A. Fawzy,et al.  Diagnostic Significance of miR-639 and miR-10b in Βreast Cancer Patients , 2019, Meta Gene.

[81]  W. Wurst,et al.  miR‐191 modulates B‐cell development and targets transcription factors E2A, Foxp1, and Egr1 , 2018, European journal of immunology.

[82]  Atef A Bassyouni,et al.  Plasma endoglin in Type2 diabetic patients with nephropathy. , 2019, Diabetes & metabolic syndrome.

[83]  J. Burger,et al.  The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia , 2018, Leukemia.

[84]  Ita Novita Sari,et al.  Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells , 2018, Cells.

[85]  M. Podhorecka,et al.  Abnormal microRNA expression in the course of hematological malignancies , 2018, Cancer management and research.

[86]  I. Berindan‐Neagoe,et al.  Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome , 2018, Critical reviews in clinical laboratory sciences.

[87]  Qingsheng Li,et al.  Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway. , 2018, Biochemical and biophysical research communications.

[88]  V. Beneš,et al.  MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells , 2018, Leukemia.

[89]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[90]  J. Byrd,et al.  iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. , 2018, Blood.

[91]  Xin Wang,et al.  Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia. , 2018, Oncology reports.

[92]  L. Mureşan,et al.  Activation of the Notch Signaling Pathway In Vivo Elicits Changes in CSL Nuclear Dynamics , 2018, Developmental cell.

[93]  I. Aurer,et al.  Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017 , 2018, Acta clinica Croatica.

[94]  Cheng Chen,et al.  New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications , 2018, Molecular Cancer.

[95]  J. Stenvang,et al.  State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia , 2018, Journal of cellular physiology.

[96]  R. Claus,et al.  Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia , 2017, Haematologica.

[97]  F. Bosch,et al.  Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia , 2017, Scientific Reports.

[98]  Jay W. Shin,et al.  An integrated expression atlas of miRNAs and their promoters in human and mouse , 2017, Nature Biotechnology.

[99]  Jeffrey A Jones,et al.  The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia , 2017, Cancer medicine.

[100]  A. Abulsoud,et al.  Clinical significance of TNFAIP3 rs2230926 T > G gene polymorphism in Egyptian cases with rheumatoid arthritis , 2017 .

[101]  S. Leprêtre,et al.  miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study , 2017, Haematologica.

[102]  Juan Fan,et al.  MiR-155 up-regulated by TGF-β promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells in vitro. , 2017, American journal of translational research.

[103]  Shile Huang,et al.  Understanding of leukemic stem cells and their clinical implications , 2017, Molecular Cancer.

[104]  J. Byrd,et al.  Comparative Evaluation of Prognostic Factors That Assess the Natural History of Chronic Lymphocytic Leukemia , 2016 .

[105]  T. Lange,et al.  Intracellular and extracellular microRNA: An update on localization and biological role. , 2016, Progress in histochemistry and cytochemistry.

[106]  Jin-shan Ye,et al.  miR-155 Regulated Inflammation Response by the SOCS1-STAT3-PDCD4 Axis in Atherogenesis , 2016, Mediators of inflammation.

[107]  Helen Zhang,et al.  The mirn23a microRNA cluster antagonizes B cell development , 2016, Journal of leukocyte biology.

[108]  A. Sahebkar,et al.  Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia , 2016, Cancer Gene Therapy.

[109]  J. Kjems,et al.  Argonaute-associated short introns are a novel class of gene regulators , 2016, Nature Communications.

[110]  R. Bociek,et al.  Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL. , 2016, Blood.

[111]  K. Stamatopoulos,et al.  B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4 , 2016, The Journal of Immunology.

[112]  C. Croce,et al.  Novel mechanisms of regulation of miRNAs in CLL. , 2016, Trends in cancer.

[113]  Yongping Song,et al.  ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development , 2015, Journal of Hematology & Oncology.

[114]  J. Byrd,et al.  Epigenetic silencing of miR‐708 enhances NF‐κB signaling in chronic lymphocytic leukemia , 2015, International journal of cancer.

[115]  S. Hammond.  An overview of microRNAs. , 2015, Advanced drug delivery reviews.

[116]  A. Jauch,et al.  p53-dependent non-coding RNA networks in chronic lymphocytic leukemia , 2015, Leukemia.

[117]  D. Casero,et al.  MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1 , 2015, Oncotarget.

[118]  G. Macino,et al.  Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR‐132 and miR‐212 , 2015, Genes, chromosomes & cancer.

[119]  C. Croce,et al.  Role of microRNA in chronic lymphocytic leukemia onset and progression , 2015, Journal of Hematology & Oncology.

[120]  A. Veronese,et al.  Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia , 2014, Leukemia.

[121]  S. Ray,et al.  Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics. , 2015, Advanced drug delivery reviews.

[122]  Emanuela M. Ghia,et al.  MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. , 2014, Blood.

[123]  Emanuela M. Ghia,et al.  miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. , 2014, Blood.

[124]  Yueqing Bai,et al.  miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1 , 2014, Journal of experimental & clinical cancer research : CR.

[125]  C. Vergin,et al.  Prospective Evaluation of Whole Genome MicroRNA Expression Profiling in Childhood Acute Lymphoblastic Leukemia , 2014, BioMed research international.

[126]  L. Feng,et al.  Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53−/− mouse model and primary human leukemia cells , 2014, Leukemia.

[127]  K. Haider,et al.  Sonic hedgehog signalling pathway: a complex network , 2014, Annals of neurosciences.

[128]  Christian Billard,et al.  Apoptosis inducers in chronic lymphocytic leukemia , 2013, Oncotarget.

[129]  G. Calin,et al.  MicroRNAs as main players in the pathogenesis of chronic lymphocytic leukemia. , 2014, MicroRNA.

[130]  Nara Lee,et al.  Mammalian 5′-Capped MicroRNA Precursors that Generate a Single MicroRNA , 2013, Cell.

[131]  Xin Wang,et al.  Role of signaling pathways and miRNAs in chronic lymphocytic leukemia , 2013, Chinese medical journal.

[132]  H. Lodish,et al.  MicroRNA-126–mediated control of cell fate in B-cell myeloid progenitors as a potential alternative to transcriptional factors , 2013, Proceedings of the National Academy of Sciences.

[133]  Rudolf Grosschedl,et al.  Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells , 2013, Nature Immunology.

[134]  F. Bazzoni,et al.  Negative regulation of Toll-like receptor 4 signaling by IL-10–dependent microRNA-146b , 2013, Proceedings of the National Academy of Sciences.

[135]  W. Vainchenker,et al.  JAK/STAT signaling in hematological malignancies , 2013, Oncogene.

[136]  R. Dahiya,et al.  Frizzled homolog proteins, microRNAs and Wnt signaling in cancer , 2013, International journal of cancer.

[137]  M. Muzio,et al.  In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors , 2012, Clinical Cancer Research.

[138]  H. Döhner,et al.  Impact of serum storage conditions on microRNA stability , 2012, Leukemia.

[139]  Y. Mo,et al.  The Akt-associated microRNAs , 2012, Cellular and Molecular Life Sciences.

[140]  Roberta Galli,et al.  MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.

[141]  Jian-yong Li,et al.  miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. , 2012, Carcinogenesis.

[142]  D. Harrison,et al.  The Jak/STAT pathway. , 2012, Cold Spring Harbor perspectives in biology.

[143]  S. Volinia,et al.  The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes , 2012, Leukemia.

[144]  Rajesh R. Singh,et al.  Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms. , 2012, The American journal of pathology.

[145]  Stefano Volinia,et al.  miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. , 2011, Blood.

[146]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[147]  Jiri Zavadil,et al.  MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. , 2011, Blood.

[148]  Shuqiang Li,et al.  MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells , 2011, PloS one.

[149]  Xia Shan,et al.  miR‐181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines , 2010, International journal of cancer.

[150]  E. Lai,et al.  Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis , 2010, Proceedings of the National Academy of Sciences.

[151]  Zhiwei Wang,et al.  Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. , 2010, Cancer Letters.

[152]  G. Hannon,et al.  A dicer-independent miRNA biogenesis pathway that requires Ago catalysis , 2010, Nature.

[153]  S. Hammond,et al.  Emerging paradigms of regulated microRNA processing. , 2010, Genes & development.

[154]  A. Pettitt,et al.  Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition , 2010, Haematologica.

[155]  M. Ferracin,et al.  MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia , 2010, Molecular Cancer.

[156]  Satoshi Shibata,et al.  A High-Resolution Structure of the Pre-microRNA Nuclear Export Machinery , 2009, Science.

[157]  C. Croce,et al.  Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. , 2009, Blood.

[158]  L. Harries,et al.  Investigating the Targets of MIR-15a and MIR-16-1 in Patients with Chronic Lymphocytic Leukemia (CLL) , 2009, PloS one.

[159]  G. Marti,et al.  Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity , 2009, Molecular Cancer Therapeutics.

[160]  D. Mukhopadhyay,et al.  Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. , 2009, Blood.

[161]  Š. Pospíšilová,et al.  miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities , 2009, Leukemia.

[162]  Robert Blelloch,et al.  Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. , 2008, Genes & development.

[163]  L. Peterson,et al.  Dysregulated angiogenesis in B-chronic lymphocytic leukemia: Morphologic, immunohistochemical, and flow cytometric evidence , 2008, Diagnostic pathology.

[164]  Jing Wang,et al.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.

[165]  M. Goodman,et al.  Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002 , 2008, Cancer Causes & Control.

[166]  H. Hermeking.  p53 enters the microRNA world. , 2007, Cancer cell.

[167]  M. Zago,et al.  miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia , 2007 .

[168]  N. Rajewsky,et al.  MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb , 2007, Cell.

[169]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[170]  M. Todesco,et al.  Target mimicry provides a new mechanism for regulation of microRNA activity , 2007, Nature Genetics.

[171]  D. Bartel,et al.  Intronic microRNA precursors that bypass Drosha processing , 2007, Nature.

[172]  Pablo Landgraf,et al.  Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. , 2007, Blood.

[173]  Chris Sander,et al.  Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. , 2007, Blood.

[174]  V. Kim,et al.  Processing of intronic microRNAs , 2007, The EMBO journal.

[175]  Adam A. Margolin,et al.  NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth , 2006, Proceedings of the National Academy of Sciences.

[176]  C. Croce,et al.  Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. , 2006, Seminars in oncology.

[177]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[178]  S. Akira,et al.  TLR signaling. , 2006, Current topics in microbiology and immunology.

[179]  Y. Pekarsky,et al.  Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.

[180]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[181]  V. Kim,et al.  The Drosha-DGCR8 complex in primary microRNA processing. , 2004, Genes & development.

[182]  G. Hannon,et al.  Processing of primary microRNAs by the Microprocessor complex , 2004, Nature.

[183]  A. Bradley,et al.  Identification of mammalian microRNA host genes and transcription units. , 2004, Genome research.

[184]  L. Coussens,et al.  Cancer: An inflammatory link , 2004, Nature.

[185]  Eric Westhof,et al.  Single Processing Center Models for Human Dicer and Bacterial RNase III , 2004, Cell.

[186]  Peter F Stadler,et al.  Molecular evolution of a microRNA cluster. , 2004, Journal of molecular biology.

[187]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.